Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Huma, founded in 2011 and headquartered in London, UK, is a leading digital health technology company specializing in AI-powered healthcare solutions. The company offers remote patient monitoring systems, decentralized clinical trials, and companion apps to support patients through treatment and drug therapies. Huma's innovative products serve various sectors, including healthcare systems, pharmaceuticals, and medtech industries.
Since its inception, Huma has demonstrated significant growth and attracted substantial investment. The company has successfully raised $367.6 million across multiple funding rounds, including a recent Series D round in July 2024 that raised $80 million at a reported valuation of $1 billion. This funding history showcases investor confidence in Huma's potential and market position.
Huma's competitive landscape includes notable players such as Biofourmis, Medable, and Owkin, with some competitors already achieving unicorn status. The company's strong funding history and innovative product offerings position it well within the rapidly growing digital health sector.
While there is no official news regarding Huma's IPO prospects, the company's substantial funding rounds and reported valuation could potentially indicate future considerations for going public. However, it's important to note that any discussions about a potential Huma IPO remain speculative at this time. Factors that could influence any future IPO decision might include market conditions, the company's financial performance, and strategic growth plans.
Investors interested in the digital health sector should keep an eye on Huma's developments, as the company continues to expand its presence in the healthcare technology market. As always, potential investors should conduct thorough research and consider market conditions before making any investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Huma's IPO timeline remains uncertain, investors interested in the digital health and AI-driven healthcare space don't have to wait on the sidelines. At Linqto, we offer accredited investors the opportunity to access interests in promising private companies like Huma before they go public. Our platform provides a unique way to diversify your portfolio with pre-IPO investments in potential healthcare technology leaders, with lower minimum investments than traditional private equity opportunities. By investing early through Linqto, you could potentially benefit from the growth and innovation in the digital health sector.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
